-
-
-
-
-
-
-
Organovo (ONVO) Appoints Norman Staskey as CFO
-
-
-
-
-
-
-
Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
-
-
-
-
-
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

